Axsome Therapeutics Inc (MIL:1AXSM)
€ 214.7 -1.5 (-0.69%) Market Cap: 11.06 Bil Enterprise Value: 10.99 Bil PE Ratio: 0 PB Ratio: 225.46 GF Score: 31/100

Axsome Therapeutics Inc at Goldman Sachs Healthcare Conference Transcript

Jun 8, 2026 / 07:20 PM GMT
Release Date Price: €202.4


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

AXSM.OQ - Axsome Therapeutics Inc
Axsome Therapeutics Inc at Goldman Sachs Healthcare Conference
Jun 08, 2026 / 07:20PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Good afternoon. Welcome to our next session. It is my pleasure to be hosting Exxon Therapeutics with Nick and Mark, CFO and COO of the company. Nick and Mark, welcome. Great to host you guys.

This is the first time that I'm hosting you guys at the GS Conference. So very excited to really appreciate it. Have this conversation with you. So before we go through all the questions, I'm going to turn it to you guys for opening remarks.

--------------------------------------------------------------------------------
Unidentified_2 [2]
--------------------------------------------------------------------------------
Sure, no, great. And thanks for having us, Richard. It's really good to
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot